8-K - Voyager Therapeutics, Inc. (0001640266) (Filer)
Published . Updated .
Key takeaways
- 8-K - Voyager Therapeutics filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
- Exposed: VYGR
- Market reaction: VYGR +2.0% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
8-K - Voyager Therapeutics filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
Directly affected
- VYGR Voyager Therapeutics-14.2% 12d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Voyager Therapeutics belongs to, so it often moves with news about it.
- AMGN Amgen+15.9% 30d
Amgen is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+16.4% 30d
Gilead Sciences is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+22.4% 30d
Moderna is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-11.9% 9d
argenx SE is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| VYGR | -0.29% | +6.67% | base | +7.83% | +14.78% | +6.09% | +2.03% |
| XLV | -0.17% | -0.64% | base | -0.06% | +1.85% | +2.11% | +2.13% |
| AMGN | +1.22% | +0.14% | base | +0.18% | +1.02% | +0.98% | +1.66% |
| GILD | +2.05% | -0.01% | base | +0.05% | +1.12% | +2.00% | +1.30% |
| MRNA | -8.19% | -5.38% | base | +9.11% | +11.44% | +3.85% | +3.03% |
| ARGX | -0.15% | +0.79% | base | +3.15% | +7.74% | +8.78% | +9.35% |
| RVMD | +7.60% | +9.18% | base | +9.36% | +12.59% | +8.59% | +1.58% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-05 AccNo: 0001193125-26-449728 Size: 514 KB Item 2.01: Completion of Acquisition or Disposition of Assets
Source: sec-edgar
The price since 5 Nov 2026: Voyager Therapeutics (VYGR) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | that day | +0.18% | final price |
| AMGN | the next day | +1.02% | final price |
| AMGN | two days later | +0.98% | final price |
| AMGN | three days later | +1.66% | final price |
| AMGN | three days earlier | +0.14% | final price |
| AMGN | five days earlier | +1.22% | final price |
| ARGX | that day | +3.15% | final price |
| ARGX | the next day | +7.74% | final price |
| ARGX | two days later | +8.78% | final price |
| ARGX | three days later | +9.35% | final price |
| ARGX | three days earlier | +0.79% | final price |
| ARGX | five days earlier | -0.15% | final price |
| GILD | that day | +0.05% | final price |
| GILD | the next day | +1.12% | final price |
| GILD | two days later | +2.00% | final price |
| GILD | three days later | +1.30% | final price |
| GILD | three days earlier | -0.01% | final price |
| GILD | five days earlier | +2.05% | final price |
| MRNA | that day | +9.11% | final price |
| MRNA | the next day | +11.44% | final price |
| MRNA | two days later | +3.85% | final price |
| MRNA | three days later | +3.03% | final price |
| MRNA | three days earlier | -5.38% | final price |
| MRNA | five days earlier | -8.19% | final price |
| RVMD | that day | +9.36% | final price |
| RVMD | the next day | +12.59% | final price |
| RVMD | two days later | +8.59% | final price |
| RVMD | three days later | +1.58% | final price |
| RVMD | three days earlier | +9.18% | final price |
| RVMD | five days earlier | +7.60% | final price |
| Voyager Therapeutics (VYGR) | that day | +7.83% | final price |
| Voyager Therapeutics (VYGR) | the next day | +14.78% | final price |
| Voyager Therapeutics (VYGR) | two days later | +6.09% | final price |
| Voyager Therapeutics (VYGR) | three days later | +2.03% | final price |
| Voyager Therapeutics (VYGR) | three days earlier | +6.67% | final price |
| Voyager Therapeutics (VYGR) | five days earlier | -0.29% | final price |
| XLV | that day | -0.06% | final price |
| XLV | the next day | +1.85% | final price |
| XLV | two days later | +2.11% | final price |
| XLV | three days later | +2.13% | final price |
| XLV | three days earlier | -0.64% | final price |
| XLV | five days earlier | -0.17% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 3 Nov 2026. That is 2 days before publication. Filed 12 Nov 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 21 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 44 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 87 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Gilbert Cisneros bought Moderna (MRNA), worth $1,001 - $15,000 on 20 Oct 2026. That is 16 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 42 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $1,001 - $15,000 on 27 Oct 2026. That is 9 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $1,001 - $15,000 on 15 Oct 2026. That is 21 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $15,001 - $50,000 on 14 Oct 2026. That is 22 days before publication. Filed 10 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Voyager Therapeutics (VYGR)
Companies mentioned with this story
- VYGR Voyager Therapeutics
Voyager Therapeutics (VYGR) is linked, with no stored direction, high confidence in the 5 Nov 2026 story “8-K - Voyager Therapeutics, Inc. (0001640266) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> VYGR
How “8-K - Voyager Therapeutics, Inc. (0001640266) (Filer)” reaches Voyager Therapeutics (VYGR)
On 5 Nov 2026, “8-K - Voyager Therapeutics, Inc. (0001640266) (Filer)” is the story that connects Voyager Therapeutics (VYGR) to this story.
For Voyager Therapeutics (VYGR), the reason on file says SEC 8-K filing -> direct issuer disclosure -> VYGR
Dates in the story, and the Voyager Therapeutics (VYGR) price range
VYGR traded between 1.68 and 2.29 across 12 sessions. The latest close on file is 1.88.
A simple score for Voyager Therapeutics (VYGR)
14 out of 100
“8-K - Voyager Therapeutics, Inc. (0001640266) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.